Vascular dementia: Changing the paradigm;Vaskuläre demenz: Ein paradigmenwechsel steht an

Klinische Neuroradiologie

Volumn 14, Issue 2, 2004, Pages 138-139

  Hentschel, F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR;

ALZHEIMER DISEASE; BRAIN INFARCTION; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; INCIDENCE; MULTIINFARCT DEMENTIA; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK FACTOR; SYMPTOMATOLOGY;

EID: 2942590406     PISSN: 09397116     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (8)

1. Cory-Bloom J. Galantamine: a review of its use in Alzheimer's disease and vascular dementia. Int J Clin Prac 2003;57:219-23.
2. Damian M, Kreis M, Krumm B, et al. Diskriminante Validität neuropsychologischer Verfahren in der Demenzdiagnostik. Z Neuropsychol 2003;14:271-82.
3. DeLaTorre JC. Alzheimer disease as a vascular disorder. Stroke 2002; 33:1152-62.
4. Hirono N, Yasuda M, Tanimukai S, et al. Effects of the Apolipoprotein E4 allele on white matter hyperintensities in dementia. Stroke 2000;31:1263-8.
5. Iadecola C, Gorelick PB. Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Stroke 2003;34:335-7.
6. Kessler H, Bleich S, Falkai P, Supprian T. Homozystein und Demenzerkrankungen. Fortschr Neurol Psychiat 2003;71:150-6.
7. Royall DR. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2003;33:2147.
8. Schmidt R, Schmidt H, Fazekas F. Vascular risk factors in dementia. J Neurol 2000;247:81-7.